English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 28, 2025

Insmed ends Brinsupri program after mid-stage trial fails in sinusitis

Patient Daily | Dec 28, 2025

FDA partially halts Merck and Daiichi Sankyo’s lung cancer drug trial after patient deaths

Patient Daily | Dec 28, 2025

Takeda reports positive phase III results for AI-designed plaque psoriasis drug

Patient Daily | Dec 28, 2025

BioMarin acquires Amicus Therapeutics for $4.8 billion to expand rare disease treatments

Patient Daily | Dec 28, 2025

Cytokinetics awaits FDA decision on aficamten for hypertrophic cardiomyopathy

Patient Daily | Dec 28, 2025

Kyowa Kirin may see higher demand after newborn screening list expands

Patient Daily | Dec 28, 2025

Researchers compile global catalog of stem cell lines for clinical use

Patient Daily | Dec 28, 2025

Chitose Laboratory and Fujifilm Biosciences partner to enhance global biopharmaceutical manufacturing

Trending

+ Regulatory
Patient Daily | Mar 5, 2026

TPA Director: RFK Jr.'s 'latest ideological crusade would be great for trial lawyers, but terrible for millions of patients'

+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Gene therapies for sickle cell disease face slow uptake despite early promise

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others

+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'

  • « First
  • «
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily